about
Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).Identifying Sarcopenia in Metabolic Syndrome: Data from the Berlin Aging Study II.Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II.Lung function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II.[Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].Relative Leukocyte Telomere Length, Hematological Parameters and Anemia - Data from the Berlin Aging Study II (BASE-II).Association between Metabolic Syndrome and Bone Mineral Density--Data from the Berlin Aging Study II (BASE-II).Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).Sleep, Muscle Mass and Muscle Function in Older PeopleExercise at Different Ages and Appendicular Lean Mass and Strength in Later Life: Results From the Berlin Aging Study II.Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin.Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany.Historical trends in modifiable indicators of cardiovascular health and self-rated health among older adults: Cohort differences over 20 years between the Berlin Aging Study (BASE) and the Berlin Aging Study II (BASE-II).Poor glucose regulation is associated with declines in well-being among older men, but not womenDifferent treatment forms of type II diabetes and the risk of dementia in German health claims dataType II diabetes and dementia
P50
Q30886859-40FBC3D2-14E4-485F-923D-02C23374C2A6Q30986817-580A5299-5158-4873-B14C-5E9FC3872AF9Q30999453-CA2638E1-BCFC-4086-AFAE-27FCE0970639Q31012073-29E67F3D-F86F-486E-8FB2-ED9369318DE8Q31012080-80D223EB-AC61-4621-8D53-2F891E618DECQ31040750-1F0E71CE-CAB6-4071-B473-D6BCEDA9C011Q31040771-FCC32371-E4C3-4659-A347-7D1E992C22AFQ31132903-0FB60A13-21BD-4859-9B27-A9BEB8BEF6CAQ36882862-F6AE459E-BDE5-4991-A520-4FD2319B41B5Q38386164-AAB628B5-248E-479D-80B0-781EBDF9B09BQ40060033-DD917988-E544-45C3-894E-45F183182753Q46155094-81581506-A9B1-4556-9DCF-C9929921EC2DQ49247569-65E4B2F3-DBBD-4568-87EC-EB449293CFBEQ91276236-516D85BD-8A14-42BC-B06C-0170940C180EQ92232208-C467FA1A-7C64-4BC6-B984-AFA6C7C7E938Q92763107-EEC5B156-1FE1-4364-91CB-B3558259A38F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nikolaus Buchmann
@ast
Nikolaus Buchmann
@en
Nikolaus Buchmann
@es
Nikolaus Buchmann
@nl
type
label
Nikolaus Buchmann
@ast
Nikolaus Buchmann
@en
Nikolaus Buchmann
@es
Nikolaus Buchmann
@nl
altLabel
Buchmann N
@en
prefLabel
Nikolaus Buchmann
@ast
Nikolaus Buchmann
@en
Nikolaus Buchmann
@es
Nikolaus Buchmann
@nl
P106
P31
P496
0000-0002-4345-3515